-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

618. Acute Lymphoblastic Leukemias: Biomarkers, Molecular Markers and Minimal Residual Disease in Diagnosis and Prognosis: Poster II

Symposia: Acute Lymphoblastic Leukemias: Biomarkers, Molecular Markers and Minimal Residual Disease in Diagnosis and Prognosis Program: Oral and Poster Abstracts
Type: Poster
Sunday, December 10, 2023: 6:00 PM-8:00 PM
Halls G-H (San Diego Convention Center)

Mark Gower, PhD1, Ximing Li, BS2, Alicia Aguilar-Navarro1*, Brian Lin, BS1*, Minerva Fernandez, MSc1*, Gibran Edun, BS3*, Mursal Nader4*, Andrea Arruda5*, Anne Maria Tierens, MD, PhD6, Elvin Wagenblast, PhD7, Lin Yang, BS1*, Ho Seok Lee, BS1*, Sanam Loghavi, MD8, John E. Dick, PhD9,10, Mark D. Minden9*, Johann K. Hitzler, MD11, Courtney L Jones, PhD12, Gregory Schwartz, PhD1*, Igor Dolgalev, PhD13*, Soheil Jahangiri, PhD9* and Anastasia N. Tikhonova, PhD9

1University Health Network, Toronto, ON, Canada
2University of Toronto, Toronto, ON, CAN
3University of Guelph, Guelph, ON, Canada
4University Health Network, Toronto, ON, CAN
5Princess Margaret Cancer Centre, University Health Network, Toronto, Canada
6Laboratory Medicine Program, University Health Network, Toronto, ON, Canada
7The Mount Sinai Hospital, Icahn School of Medicine, New York
8Hematopathology, MD Anderson Cancer Center, Houston, TX
9Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
10Department of Molecular Genetics, University of Toronto, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, CAN
11Division Hematology/Oncology, The Hospital for Sick Children, Toronto, ON, CAN
12Princess Margaret Cancer Centre, University Health NetworkCin, Toronto, ON, Canada
13NYU Grossman School of Medicine, New York, NY

Laura Oksa1*, Sanni Moisio, MSc2*, Khurram Maqbool, PhD3,4*, Hassan Foroughi-Asl4,5*, Roger Kramer2*, Atte Nikkilä, MD, PhD1*, Kaisa Vepsäläinen, MD, PhD6*, Jesus Duque-Afonso, MD7*, Julia Hauer8*, Jessica Nordlund9*, Valtteri Wirta4,5*, Olli Lohi1 and Merja Heinäniemi2*

1Tampere Center for Child, Adolescent, and Maternal Health Research, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland
2Institute of Biomedicine, School of Medicine, University of Eastern Finland, Kuopio, Finland
3Department of Microbiology, Tumor and Cell biology, Karolinska Institutet, Stockholm, AL, Sweden
4Clinical Genomics facility, Science for Life Laboratory, Stockholm & Uppsala, Stockholm, Sweden
5Department of Microbiology, Tumor and Cell biology, Karolinska Institutet, Stockholm, Sweden
6Kuopio University Hospital, Kuopio, FIN
7Univ. of Freiburg, Freiburg, DEU
8Technical University of Munich, School of Medicine, Department of Pediatrics, Munich, Germany
9Department of Medical Sciences and Science for Life Laboratory, Uppsala University, Uppsala, Sweden

Junyu Wang, PhD1*, Tuantuan Gui, Master1*, Tong Yin, MD, PhD1*, Yuting Dai, PhD1*, Jing Qiao, Master1*, Jianfeng Li, PhD1*, Jie Xu1, Yuanfang Liu1*, Yan Wang, MD, PhD1*, Yun Tan, PhD1*, Bo Jiao, PhD1*, Yongmei Zhu1*, Zhu Chen, MD, PhD1*, Wenlian Chen, PhD2*, Hai Fang, PhD1*, Jian Hou, MD, PhD3*, Jian-Qing Mi, MD, PhD1*, Jin Wang1* and Sai-Juan Chen, MD, PhD1*

1National Research Center for Translational Research at Shanghai, Shanghai Institute of Hematology, Ruijin Hospital, Shanghai JiaoTong University School of Medicine (SJTUSM), Shanghai, China
2Cancer Institute, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China
3Department of Hematology, Renji Hospital, SJTUSM, Shanghai, China

Carol Fries Simpson, MD1, Yuxuan Liu, PhD2, Lucille Stuani, PhD3*, Astraea Jager2*, Cameron Baker4*, Diana G. Adlowitz, PhD5*, Philip J Rock6*, Richard Burack, MD, PhD6 and Kara L. Davis, DO2

1Department of Pediatrics, University of Rochester, Rochester, NY
2Department of Pediatrics, Hematology, Oncology, and Stem Cell Transplant and Regenerative Medicine, Stanford University, Stanford, CA
3Stanford University, Stanford, CA
4Genomics Research Center, University of Rochester, Rochester, NY
5Department of Pediatrics; Department of Pathology & Laboratory Medicine, University of Rochester, Rochester, NY
6Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, NY

Chi Zhang1*, Kathy Yuen Yee Chan, PhD1*, John Tak Kit Cheung2*, Wing Hei Ng, BSc2*, Chi Kong Li1 and Kam Tong Leung1*

1Department of Paediatrics, The Chinese University of Hong Kong, Shatin, Hong Kong
2Department of Paediatrics, The Chinese University of Hong Kong, Hong Kong, Hong Kong

Lai N Chan, PhD1,2, Kohei Kume, PhD1*, Christian Hurtz, PhD3, Mark E Robinson, PhD1*, Kadriye Nehir Cosgun, PhD1* and Markus Müschen, MD1

1Center of Molecular and Cellular Oncology, Yale University, New Haven, CT
2Department of Cancer Biology, Cleveland Clinic, Cleveland, OH
3Lewis Katz School of Medicine, Temple University, Philadelphia, PA

Guanglan Lin, MS1*, Kathy Yuen Yee Chan, PhD2*, Qiwei SUN3*, Wing Kwan Leung, MD4*, Chi Kong Li2 and Kam Tong Leung2*

1Chinese university of HongKong, Hongkong, AL, Hong Kong
2Department of Paediatrics, The Chinese University of Hong Kong, Shatin, Hong Kong
3Department of Paediatrics, The Chinese University of Hong Kong, Hong Kong, Hong Kong
4Chinese university of HongKong, Hong Kong, HKG

Ntasha Roy1*, Zhengwei (Jenny) Mao, MD (co-first author)2*, Chang Xu, PhD2*, David T. Teachey, MD3, Zhiguo (Bruce) Chen, MS4*, Meenakshi Devidas, PhD, MBA5, Xueyan Chen, MD, PhD6*, Elizabeth A. Raetz, MD7, Mignon L. Loh, MD8, Stephen P. Hunger, MD9 and Brent L. Wood, MD, PhD1,10

1Department of Pathology and Laboratory Medicine, Children's Hospital Los Angeles, Los Angeles, CA
2Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA
3Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA
4Biostatistics, University of Florida, Gainesville, FL
5St Jude Children's Research Hospital, Memphis, TN
6Fred Hutchinson Cancer Center, Seattle, WA
7Department of Pediatrics, NYU Langone Health, New York, NY
8Ben Towne Center for Childhood Cancer Research, Seattle Children’s Hospital, Seattle, WA
9Childrens Hospital of Philadelphia, Philadelphia
10Department of Laboratory Medicine, University of Washington, Seattle, WA

Kohei Kume, PhD1*, Zhengshan Chen, MD-PhD2*, Mark E Robinson, PhD1*, Lai N Chan, PhD1, Etienne Leveille, MD-PhD1*, Kadriye Nehir Cosgun, PhD1*, Zhangliang Cheng1*, David Fonseca Arce1*, Dhruv Khanduja1*, Thomas Graeber, PhD2* and Markus Müschen, MD1

1Center of Molecular and Cellular Oncology, Yale University, New Haven, CT
2Metabolomics Center, University of California Los Angeles, Los Angeles, CA

Louise Ahlgren, PhD1*, Mattias Pilheden, PhD1*, Helena Sturesson, PhD1*, Varsha Singh, PhD1*, Qirui Zhang, PhD1*, Michael Walsh, MD2*, Guangchun Song2*, Anders Castor3*, Cornelis Jan Pronk, MD, PhD3*, Pauline Schneider4*, Ronald W. Stam, PhD4*, Gisela Barbany5*, Katja Pokrovskaja Tamm, PhD6*, Jonas Abrahamsson7*, Linda Fogelstrand, MD, PhD8, Olli Lohi, MD, PhD9, Jing Ma, PhD2*, Jinghui Zhang, PhD10* and Anna K. Hagstroem-Andersson, PhD1

1Department of Laboratory Medicine, Division of Clinical Genetics, Lund University, Lund, Sweden
2Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN
3Childhood Cancer Center, Skåne University Hospital, Lund, Sweden
4Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands
5Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden
6Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden
7Institution for Clinical Sciences, Department of Pediatrics, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden, Gothenburg, Sweden
8Department of Clinical Chemistry, Sahlgrenska University, Gothenburg, Sweden
9Tampere Center for Child, Adolescent and Maternal Health Research, Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Center, Tampere University Hospital, Tampere, Finland
10Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, TN

Min Sui1*, Huideng Long2*, Chunhua Song, MD, PhD3,4 and Zheng Ge, MD, PhD2

1Department of Hematology, Zhongda Hospital, School of Medicine, Southeast University, Institute of Hematology Southeast University, Nanjing, China, China
2Department of Hematology, Zhongda Hospital, School of Medicine, Southeast University, Institute of Hematology Southeast University, Nanjing, China
3Hershey Medical Center, Pennsylvania State University Medical College, Hershey, PA
4Division of Hematology, The Ohio State University Wexner Medical Center and The James Cancer Hospital, Columbus, OH

Estelle Balducci1,2*, Mathieu Simonin, MD, PhD1,2*, Nicolas Duployez, PharmD, PhD3,4*, Thomas Steimlé, MD1,2*, Marie-Emilie Dourthe, MD, PhD1,2*, Patrick Villarese, PhD1,2*, Stéphane Ducassou, MD, PhD5*, Isabelle Arnoux, PharmD6*, Jean-Michel Cayuela, PharmD, PhD7*, Marie Balsat, MD8*, Lucien Courtois, PharmD1,2*, Guillaume P Andrieu, PhD1,2*, Aurore Touzart, MD, PhD1,2*, Françoise Huguet, M.D.9*, Arnaud Petit, MD, PhD10*, Norbert Ifrah, MD, PhD11, Hervé Dombret, MD, PhD12, André Baruchel, MD, PhD13,14, Claude Preudhomme, PharmD, PhD3,4*, Nicolas Boissel, MD, PhD12* and Vahid Asnafi, MD, PhD1,2*

1Laboratory of Onco-Hematology, Necker Children's Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France
2INSERM U1151, Institut Necker Enfants Malades (INEM), Paris, France
3INSERM U1277 CANTHER, Univ. Lille, Lille, France
4Laboratory of Hematology, Centre Hospitalier Universitaire (CHU) Lille, Lille, France
5Service d'onco-hématologie pédiatrique, Hôpital Pellegrin Tripode, Bordeaux, France
6Laboratory of Hematology, La Timone University Hospital, Assitance Publique des Hôpitaux de Marseille (AP-HM), Marseille, France
7Laboratory of Hematology and EA 3518 University Hospital Saint-Louis, AP-HP and Université de Paris, Paris, France
8Clinical Hematology Department, Hospices Civils de Lyon, Lyon Sud Hospital, Pierre-Bénite, France, Lyon, France
9Hematology Department, Institut Universitaire du Cancer-Oncopole, CHU de Toulouse, Toulouse, France
10Department of Pediatric Hematology and Oncology, Assistance Publique-Hôpitaux de Paris (AP-HP), GH HUEP, Armand Trousseau Hospital, Paris, France
11PRES LUNAM, CHU Angers Service des Maladies du Sang and INSERM U 892, Angers, France
12Université Paris Diderot, Institut Universitaire d'Hématologie, EA-3518, Assistance Publique-Hôpitaux de Paris, University Hospital Saint-Louis, Paris, France
13Institut Universitaire d'Hématologie, EA-3518, University Hospital Saint-Louis, Assistance Publique des Hôpitaux de Paris (APHP), Paris, France
14Department of Pediatric Hematology and Immunology, University Hospital Robert Debré, Assistance Publique des Hôpitaux de Paris (APHP), Paris, France

Jacob J. Junco, PhD1*, Raushan Rashid1*, Maci Terrell1*, Michelle Alozie1*, Max Rochette1*, Barry Zorman, PhD1*, Pavel Sumazin, PhD1*, Lauren Rowland2*, Gino Dettorre2*, Reid T. Powell, PhD3*, Clifford C. Stephan, PhD3*, Peter J. Davies, MD, PhD3*, Margie M. Moczygemba, PhD3*, Jun J. J. Yang, PhD4 and Karen R. Rabin, MD, PhD5

1Department of Pediatrics, Baylor College of Medicine, Texas Children's Cancer Center, Houston, TX
2Department of Pharmacy and Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN
3Institute of Biosciences and Technology, Texas A&M University, Center for Translational Cancer Research, Houston, TX
4Department of Pharmacy and Pharmaceutical Sciences, St. Jude Children's Research Hospital, MEMPHIS, TN
5Department of Pediatrics, Baylor College of Medicine, Baylor College of Medicine TX Children's Cancer Center, Houston, TX

Luca Lo Nigro, MD1, Daria La Cognata, MD2*, Nellina Andriano, B.S.3*, Emanuela Cannata, MD, PhD4*, Manuela La Rosa, B.S.5*, Marta Arrabito, MD6* and Giovanna Russo, Professor7*

1Cytogenetic-Cytofluorimetric-Molecular Biology Laboratory Center of Pediatric Hematology Oncology, Azienda Policlinico "G. Rodolico",, Catania, Italy
2School of Residency in Pediatrics - University of Catania, Catania, Italy
3Ph Program in Translational Medicine - University of Catania - Italy, Catania, Italy
4Azienda Policlinico - San Marco, Catania, Catania, Italy
5Cytogenetic, Cytofluorimetric and Molecular Biology Lab - Center of Pediatric Hematology Oncology, Azienda Policlinico - San Marco, Catania, Catania, Italy
6Center of Pediatric Hematology Oncology, University of Catania - Azienda Policlinico - San Marco Catania, Catania, Italy
7Pediatric Hematology/Oncology Unit, University of Catania, Catania, Italy

Irina Pushel, PhD1*, Byunggil Yoo, MS1*, Daniel Louiselle, MS1*, Margaret Gibson, MB(ASCP)1*, Erin M. Guest, MD2, Midhat S Farooqi, MD, PhD1* and Keith J. August, MD, MS2

1Genomic Medicine Center, Children's Mercy Kansas City, Kansas City, MO
2Hematology/Oncology/BMT, Children's Mercy Kansas City, Kansas City, MO

Kathrin Liszt, PhD1,2*, Maximilian von der Linde, MS1,2*, Dagmar Schinnerl, PhD2*, Karin Nebral, PhD1,2*, Sabine Strehl, PhD3*, Andishe Attarbaschi, Prof., MD2,4*, Oskar A. Haas, MD5 and Stefan Koehrer, MD1,2,6*

1Clinical Genetics, Labdia Labordiagnostik, Vienna, Austria
2St. Anna Children´s Cancer Research Institute (CCRI), Vienna, Austria
3St. Anna Children’s Cancer Research Institute, Vienna, Austria
4Department of Pediatric Hematology and Oncology, St. Anna Children's Hospital, Medical University Vienna, Vienna, Austria
5St. Anna Children's Hospital, Vienna, Austria
6Department of Laboratory Medicine, Klinik Donaustadt, Vienna, Austria

*signifies non-member of ASH